步长制药:深耕中药出海,厚植公益底色,彰显企业担当

Core Viewpoint - The company, BuChang Pharmaceutical, is accelerating its internationalization and innovation efforts, with over 170 products included in the 2025 National Medical Insurance Directory, and is actively expanding its global market presence through strategic partnerships and product registrations [1][3][4]. Group 1: Product Development and Innovation - BuChang Pharmaceutical has 73 exclusive products in the 2025 National Medical Insurance Directory, including 63 traditional Chinese medicines, 9 chemical drugs, and 1 vaccine [1]. - The company is advancing its first-class new drug, Efparepoetin alfa, which has a cumulative R&D investment of approximately 51.24 million RMB as of September 30, 2025, and is expected to have significant market potential as it is the first of its kind in China [3]. - The company has received various product registrations in international markets, including Malaysia and Hong Kong, for its traditional Chinese medicine products, indicating successful international expansion [5]. Group 2: Policy Support and Market Expansion - A recent guideline issued by five government departments aims to enhance the overseas service ecosystem for Chinese enterprises, providing strong support for companies like BuChang to engage in international cooperation and competition [4]. - BuChang Pharmaceutical has successfully registered multiple products in various countries, including Canada, Indonesia, and Mongolia, expanding its market reach to dozens of countries across Asia, Europe, and Africa [5]. Group 3: Corporate Social Responsibility - BuChang Pharmaceutical emphasizes its commitment to social responsibility, having contributed nearly 33 billion RMB in taxes and actively engaging in public welfare projects, such as the "Together, Build the Chinese Heart" initiative, which has provided medical assistance to minority communities [7][8][12]. - The company aims to create a new paradigm of corporate citizenship by linking industrial value with social value, demonstrating a long-term commitment to community welfare and economic development [7][12].

BUCHANG PHARMA-步长制药:深耕中药出海,厚植公益底色,彰显企业担当 - Reportify